In vivo comparison of local versus systemic delivery of immunostimulating siRNA in HPV-driven tumours

Loading...
Thumbnail Image
File version

Accepted Manuscript (AM)

Author(s)
Khairuddin, Norliana
Blake, Stephen J
Firdaus, Farah
Steptoe, Raymond J
Behlke, Mark A
Hertzog, Paul J
McMillan, Nigel AJ
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2014
Size
File type(s)
Location
License
Abstract

Small interfering RNAs (siRNAs) to inhibit oncogene expression and also to activate innate immune responses via Toll-like receptor (TLR) recognition have been shown to be beneficial as anti-cancer therapy in certain cancer models. In this study, we investigated the effects of local versus systemic delivery of such immune-stimulating Dicer-substrate siRNAs (IS-DsiRNAs) on a human papillomavirus (HPV)-driven tumour model. Localized siRNA delivery using intratumour injection of siRNA was able to increase siRNA delivery to the tumour compared with intravenous (IV) delivery and potently activated innate immune responses. However, IV injection remained the more effective delivery route for reducing tumour growth. Although IS-DsiRNAs activated innate immune cells and required interferon-a (IFNa) for full effect on tumour growth, we found that potent silencing siRNA acting independently of IFNa were overall more effective at inhibiting TC-1 tumour growth. Other published work utilising IS-siRNAs have been carried out on tumour models with low levels of major histocompatibility complex (MHC)-class 1, a target of natural killer cells that are potently activated by IS-siRNA. As TC-1 cells used in our study express high levels of MHC-class I, the addition of the immunostimulatory motifs may not be as beneficial in this particular tumour model. Our data suggest that selection of siRNA profile and delivery method based on tumour environment is crucial to developing siRNA-based therapies.

Journal Title

Immunology and Cell Biology

Conference Title
Book Title
Edition
Volume

92

Issue

2

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement

© 2013 Nature Publishing Group. This is the author-manuscript version of this paper. Reproduced in accordance with the copyright policy of the publisher. Please refer to the journal website for access to the definitive, published version.

Item Access Status
Note
Access the data
Related item(s)
Subject

Biochemistry and cell biology

Immunology

Cancer therapy (excl. chemotherapy and radiation therapy)

Persistent link to this record
Citation
Collections